Therapeutic sequences in patients with grade 1−2 neuroendocrine tumors (NET): an observational multicenter study from the ELIOS group
Annamaria Colao(European Gravitational Observatory), Ferdinando Riccardi(Ospedale Antonio Cardarelli), Antongiulio Faggiano(European Neuroendocrine Tumor Society), Salvatore Tafuto(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Chiara De Divitiis, Giovannella Palmieri(Regione Campania), Roberta Modica(University of Naples Federico II), Silvana Leo, Valentina Guarnotta, Margaret Ottaviano(University of Naples Federico II), Giuseppe Badalamenti(University of Palermo), Ivana Puliafito(Istituto Oncologico Veneto), Silvana Di Maio(Ospedale Antonio Cardarelli), Antonella Bianco(Ospedale Monaldi), Carmela Mocerino(Ospedale Antonio Cardarelli), Antonella Di Sarno(Molecular Oncology (United States)), Pasquale Dolce, Lucia Tozzi(Casa Sollievo della Sofferenza)
Cited by 35
Related Papers
Systemic Complications of Acromegaly: Epidemiology, Pathogenesis, and Management
|Endocrine Reviews|2004|1.3k
Persistence of Increased Cardiovascular Risk in Patients with Cushing’s Disease after Five Years of Successful Cure
|The Journal of Clinical Endocrinology & Metabolism|1999|417
Cardiovascular Risk Factors and Common Carotid Artery Caliber and Stiffness in Patients with Cushing’s Disease during Active Disease and 1 Year after Disease Remission
|The Journal of Clinical Endocrinology & Metabolism|2003|355
Withdrawal of Long-Term Cabergoline Therapy for Tumoral and Nontumoral Hyperprolactinemia
|New England Journal of Medicine|2003|336